Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
563-01-009 ISMRM Abstract

Spatiotemporal Subtyping of Structural Progression in Hippocampal Sclerosis Using SuStaIn and Volumetric Biomarkers

Primary: Neuro - Epilepsy
Secondary: Neuro - White Matter
563-01-009 · Novel Neuro Applications · Wednesday, 13 May, 8:20 AM–9:15 AM · Digital Posters Row D
Accepted
Jinqin Li1, Bing Chen 2, Dengyan Song3, Zhuo Wang3, Yuanyuan wei3, Hao Ye3, Shanshan Jiang4, Guangxu Han5
1The First Clinical Medical College of Ningxia Medical University, The First Clinical Medical College of Ningxia Medical University, Yinchuan, China
2General Hospital of Ningxia Medical University, Yinchuan, China
3The First Clinical Medical College of Ningxia Medical University, Yinchuan, China
4Bayer Healthcare, Wuhan, China
5GE HealthCare MR Research, Beijing, China
Presenting Author: Bing Chen

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. [1] Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689-701. doi:10.1016/S0140-6736(18)32596-0. [doi]
2. [2] Corrêa DG, Pereira M, Zimmermann N, et al. Widespread white matter DTI alterations in mesial temporal sclerosis independent of disease side. Epilepsy Behav. 2018;87:7-13. doi:10.1016/j.yebeh.2018.08.013. [doi]
3. [3] Giachetti I, Padelli F, Aquino D, et al. Role of NODDI in the MRI Characterization of Hippocampal Abnormalities in Temporal Lobe Epilepsy: Clinico-histopathologic Correlations. Neurology. 2022;98(17):e1771-e1782. doi:10.1212/WNL.0000000000200140. [doi]
4. [4] Xiao F, Caciagli L, Wandschneider B, et al. Identification of different MRI atrophy progression trajectories in epilepsy by subtype and stage inference. Brain. 2023;146(11):4702-4716. doi:10.1093/brain/awad284. [doi]
5. [5] Sone D, Sato N, Shigemoto Y, Beheshti I, Kimura Y, Matsuda H. Estimated Disease Progression Trajectory of White Matter Disruption in Unilateral Temporal Lobe Epilepsy: A Data-Driven Machine Learning Approach. Brain Sci. 2024;14(10):992. Published 2024 Sep 29. doi:10.3390/brainsci14100992. [doi]
6. [6] Blümcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2013;54(7):1315-1329. doi:10.1111/epi.12220. [doi]
7. [7] Solanki C, Williams J, Andrews C, Fayed I, Wu C. Insula in epilepsy - "untying the gordian knot": A systematic review. Seizure. 2023;106:148-161. doi:10.1016/j.seizure.2023.02.019. [doi]
8. [8] Tager D, Panjeti-Moore D, Yang JC, et al. The effect of responsive neurostimulation (RNS) on neuropsychiatric and psychosocial outcomes in drug-resistant epilepsy. Epilepsy Behav. 2023;142:109207. doi:10.1016/j.yebeh.2023.109207. [doi]
9. [9] Rosazza C, Ghielmetti F, Minati L, et al. Preoperative language lateralization in temporal lobe epilepsy (TLE) predicts peri-ictal, pre- and post-operative language performance: An fMRI study. Neuroimage Clin. 2013;3:73-83. Published 2013 Jul 11. doi:10.1016/j.nicl.2013.07.001. [doi]
10. [10] Engel J Jr, McDermott MP, Wiebe S, et al. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307(9):922-930. doi:10.1001/jama.2012.220. [doi]
11. [11] Kaestner E, Reyes A. Out of one, how many? Subtyping in epilepsy. Brain. 2023;146(11):4411-4413. doi:10.1093/brain/awad354 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/563-01-009